<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29596311</article-id><article-id pub-id-type="pmc">5946209</article-id><article-id pub-id-type="doi">10.3390/nu10040424</article-id><article-id pub-id-type="publisher-id">nutrients-10-00424</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Effects of Isoflavone Supplementation Plus Combined Exercise on Lipid Levels, and Inflammatory and Oxidative Stress Markers in Postmenopausal Women</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Giolo</surname><given-names>J&#x000e9;ssica S.</given-names></name><xref ref-type="aff" rid="af1-nutrients-10-00424">1</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Juliene G.</given-names></name><xref ref-type="aff" rid="af1-nutrients-10-00424">1</xref></contrib><contrib contrib-type="author"><name><surname>da Cunha-Junior</surname><given-names>Jair P.</given-names></name><xref ref-type="aff" rid="af2-nutrients-10-00424">2</xref></contrib><contrib contrib-type="author"><name><surname>Pajuaba</surname><given-names>Ana Cl&#x000e1;udia A. M.</given-names></name><xref ref-type="aff" rid="af2-nutrients-10-00424">2</xref></contrib><contrib contrib-type="author"><name><surname>Taketomi</surname><given-names>Ernesto A.</given-names></name><xref ref-type="aff" rid="af2-nutrients-10-00424">2</xref></contrib><contrib contrib-type="author"><name><surname>de Souza</surname><given-names>Adriele V.</given-names></name><xref ref-type="aff" rid="af3-nutrients-10-00424">3</xref></contrib><contrib contrib-type="author"><name><surname>Caixeta</surname><given-names>Douglas C.</given-names></name><xref ref-type="aff" rid="af3-nutrients-10-00424">3</xref></contrib><contrib contrib-type="author"><name><surname>Peixoto</surname><given-names>Leonardo G.</given-names></name><xref ref-type="aff" rid="af3-nutrients-10-00424">3</xref></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Erick P.</given-names></name><xref ref-type="aff" rid="af4-nutrients-10-00424">4</xref></contrib><contrib contrib-type="author"><name><surname>Everman</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="af5-nutrients-10-00424">5</xref></contrib><contrib contrib-type="author"><name><surname>Espindola</surname><given-names>Foued S.</given-names></name><xref ref-type="aff" rid="af3-nutrients-10-00424">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9093-6640</contrib-id><name><surname>Puga</surname><given-names>Guilherme M.</given-names></name><xref ref-type="aff" rid="af1-nutrients-10-00424">1</xref><xref rid="c1-nutrients-10-00424" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-10-00424"><label>1</label>Laboratory of Cardiorespiratory and Metabolic Physiology, Federal University of Uberl&#x000e2;ndia, Uberl&#x000e2;ndia-MG 38400-678, Brazil; <email>sanjuliaogiolo@hotmail.com</email> (J.S.G.); <email>julienegoncalves@hotmail.com</email> (J.G.C.)</aff><aff id="af2-nutrients-10-00424"><label>2</label>Laboratory of Immunotechnology and Immunochemistry, Institute of Biomedical Sciences, Federal University of Uberl&#x000e2;ndia, Uberl&#x000e2;ndia-MG 38400-902, Brazil; <email>jair.cunha.junior@gmail.com</email> (J.P.d.C.-J.); <email>anapajuaba@gmail.com</email> (A.C.A.M.P.); <email>eat4y@yahoo.com.br</email> (E.A.T.)</aff><aff id="af3-nutrients-10-00424"><label>3</label>Laboratory of Biochemistry and Molecular Biology, Institute of Biotechnology, Federal University of Uberl&#x000e2;ndia, Uberl&#x000e2;ndia-MG 38400-902, Brazil; <email>adriele_vds@hotmail.com</email> (A.V.d.S.); <email>caixetadoug@gmail.com</email> (D.C.C.); <email>lgpeixoto@yahoo.com.br</email> (L.G.P.); <email>foued@ufu.br</email> (F.S.E.)</aff><aff id="af4-nutrients-10-00424"><label>4</label>School of Medicine, Federal University of Uberl&#x000e2;ndia, Uberl&#x000e2;ndia-MG 38400-902, Brazil; <email>erick_po@yahoo.com.br</email></aff><aff id="af5-nutrients-10-00424"><label>5</label>College of Graduate Health Studies, AT. Still University, Mesa, AZ 85206, USA; <email>severman@atsu.edu</email></aff><author-notes><corresp id="c1-nutrients-10-00424"><label>*</label>Correspondence: <email>gmpuga@gmail.com</email>; Tel.: +55-34-3218-2967</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2018</year></pub-date><volume>10</volume><issue>4</issue><elocation-id>424</elocation-id><history><date date-type="received"><day>31</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>This study tested the effect of isoflavone supplementation in addition to combined exercise training on plasma lipid levels, inflammatory markers and oxidative stress in postmenopausal women. Thirty-two healthy and non-obese postmenopausal women without hormone therapy were randomly assigned to exercise + placebo (PLA; <italic>n</italic> = 15) or exercise + isoflavone supplementation (ISO; <italic>n</italic> = 17) groups. They performed 30 sessions of combined exercises (aerobic plus resistance) over ten weeks and consumed 100 mg of isoflavone supplementation or placebo. Blood samples were collected after an overnight fast to analyze the lipid profile, interleukin-6 (IL-6), interleukin-8 (IL-8), superoxide dismutase (SOD), total antioxidant capacity (FRAP), and thiobarbituric acid reactive substances (TBARS), before and after ten weeks of the intervention. There were no differences in the changes (pre vs. post) between groups for any of the inflammatory markers, oxidative stress markers or lipid profile variables. However, interleukin-8 was different between pre- and post-tests (<italic>p</italic> &#x0003c; 0.001) in both groups (&#x00394; = 7.61 and 5.61 pg/mL) as were cholesterol levels (<italic>p</italic> &#x0003c; 0.05), with no interaction between groups. The combination of isoflavone supplementation and exercise training did not alter oxidative stress markers in postmenopausal women, but exercise training alone may increase IL-8 and decrease total cholesterol levels.</p></abstract><kwd-group><kwd>aerobic and resistance exercises</kwd><kwd>soy protein</kwd><kwd>menopause</kwd><kwd>cytokines</kwd><kwd>anti-oxidant system</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-10-00424"><title>1. Introduction</title><p>The postmenopausal period is often associated with chronic diseases, which demonstrates the importance of prevention strategies. Low-grade chronic inflammation and oxidative stress are common changes in postmenopausal women [<xref rid="B1-nutrients-10-00424" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-10-00424" ref-type="bibr">2</xref>], and regular physical exercise training and/or the consumption of phytoestrogens may be important strategies for minimizing or preventing these changes in women [<xref rid="B3-nutrients-10-00424" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-10-00424" ref-type="bibr">4</xref>].</p><p>Resistance training combined with aerobic exercise has been shown to be effective for reducing reactive oxygen species and increasing antioxidant enzymes [<xref rid="B5-nutrients-10-00424" ref-type="bibr">5</xref>], as well as reducing total cholesterol levels in obese women more than aerobic exercise alone [<xref rid="B6-nutrients-10-00424" ref-type="bibr">6</xref>]. Regular exercise also plays an important role in increasing anti-inflammatory cytokines and reducing the release of pro-inflammatory agents by adipocytes by reducing visceral and total fat [<xref rid="B4-nutrients-10-00424" ref-type="bibr">4</xref>]. Interleukin-8 (IL-8) and interleukin-6 (IL-6) are pro-inflammatory cytokines, but they perform different and beneficial functions when released by skeletal muscle via the stimulus of physical exercise. IL-8 can induce angiogenesis and IL-6 can inhibit the release of pro-inflammatory tumor necrosis factor-alfa (TNF-&#x003b1;) and interleukin 1 beta (IL-1&#x003b2;), concurrently with an increase of anti-inflammatory cytokines IL-10 and IL-1ra, when released by exercise [<xref rid="B7-nutrients-10-00424" ref-type="bibr">7</xref>].</p><p>Among the phytoestrogens found in foods, soy isoflavones are frequently used as an alternative treatment for metabolic and cardiovascular diseases, and to ameliorate symptoms that appear during postmenopausal period in women, due to their similar structure and action to estradiol [<xref rid="B8-nutrients-10-00424" ref-type="bibr">8</xref>]. Some studies have shown that the consumption of 100 mg of isoflavones per day may reduce the reactive species, malondialdehyde, in postmenopausal women [<xref rid="B3-nutrients-10-00424" ref-type="bibr">3</xref>]. In addition, 138 mg of isoflavones along with 81 mg of dadzein increased the activity of the antioxidant enzyme, superoxide dismutase, in postmenopausal women [<xref rid="B9-nutrients-10-00424" ref-type="bibr">9</xref>]. Likewise, in animal models, these compounds have been shown to improve the lipid profile and total antioxidant capacity [<xref rid="B10-nutrients-10-00424" ref-type="bibr">10</xref>].</p><p>Due to the separate anti-inflammatory and antioxidant functions of physical exercise and isoflavones, our hypothesis was that the addition of isoflavone could induce greater and/or additive benefits to those found with exercise alone. A few studies have investigated the combined effect of isoflavone supplementation and exercise, but the results are still conflicting [<xref rid="B11-nutrients-10-00424" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-10-00424" ref-type="bibr">12</xref>,<xref rid="B13-nutrients-10-00424" ref-type="bibr">13</xref>]. In fact, a clinical trial found improvements in risk factors, such as fat body mass, and inflammatory markers, such as C-reactive protein [<xref rid="B11-nutrients-10-00424" ref-type="bibr">11</xref>]. In addition, other studies showed reductions in low-density lipoprotein [<xref rid="B13-nutrients-10-00424" ref-type="bibr">13</xref>] and increased high-density lipoprotein with isoflavone supplementation and exercise in postmenopausal women [<xref rid="B12-nutrients-10-00424" ref-type="bibr">12</xref>]. In ovariectomized rats, this type of intervention was able to increase the total antioxidant capacity after 12 weeks [<xref rid="B10-nutrients-10-00424" ref-type="bibr">10</xref>]. However, few studies have investigated the effects of aerobic and resistance exercise in addition to isoflavone supplementation on inflammatory and oxidative stress markers in humans.</p><p>Therefore, the purpose of this study was to determine if the addition of isoflavone supplementation with combined aerobic and resistance exercise training has additional or better effects than exercise training alone on lipid profiles and inflammatory and oxidative stress markers in postmenopausal women.</p></sec><sec id="sec2-nutrients-10-00424"><title>2. Materials and Methods</title><p>This trial was a double-blind, randomized (electronic lottery), parallel prospective clinical trial conducted at the Laboratory of Cardiorespiratory and Metabolic Physiology at Physical Education Department at Federal University of Uberl&#x000e2;ndia, Uberl&#x000e2;ndia MG, Brazil. The study was approved by the local Ethics Committee for human studies (CAAE: 40622414.9.0000.5152), and all participants read and signed the informed consent before participation in the study. The experiments conformed to the principles set out in the World Medical Association Declaration of Helsinki. This research was registered at <uri>Clinicaltrials.gov</uri> (number: NCT03008785).</p><sec id="sec2dot1-nutrients-10-00424" sec-type="subjects"><title>2.1. Participants</title><p>This study included non-obese, postmenopausal women, aged between 50 and 70 years old. The inclusion criteria for the study were as follows: amenorrhea for at least 12 months; body mass index &#x02264;30 kg/m<sup>2</sup>; ability to engage in treadmill and resistance exercises; no history of cardiovascular disease, diabetes or high blood pressure; no hormone therapy or soy derived supplementation; non smokers; and not using drugs that alter the lipid profile. <xref ref-type="fig" rid="nutrients-10-00424-f001">Figure 1</xref> presents the flowchart with the distribution of the participants in the study.</p><p>All participants who met the inclusion criteria were randomly assigned to two different groups: exercise training and placebo supplementation (PLA) or exercise training and isoflavone supplementation (ISO). The participants also underwent anthropometric measurements, fasting blood collection, an aerobic capacity and maximal strength test (1RM) and were familiarized with the exercises and ergometers used before testing. Blood samples were collected before and after 10 weeks of isoflavone or placebo supplementation and combined aerobic and resistance exercise training.</p></sec><sec id="sec2dot2-nutrients-10-00424"><title>2.2. Supplementation</title><p>The participants in the ISO group consumed one capsule per day containing 100 mg of isoflavones (Xi&#x02019;An Green-Life Natural Products, Xian, Shaanxi, China) 33 mg of genistein, 93.5 mg of dadzein and 3.2 mg of glycitein derived from soybean and corresponding approximately 37.58 g of soy [<xref rid="B14-nutrients-10-00424" ref-type="bibr">14</xref>]. The plasma half-life of isoflavone is approximately 6&#x02013;8 h [<xref rid="B15-nutrients-10-00424" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-10-00424" ref-type="bibr">16</xref>], however metabolites derived after its ingestion may be elevated in the urine for 24 h and return to baseline in the next 48&#x02013;72 h [<xref rid="B17-nutrients-10-00424" ref-type="bibr">17</xref>]. The participants in the PLA group received 100 mg of cornstarch daily in a single capsule. All capsules were identical in appearance.</p></sec><sec id="sec2dot3-nutrients-10-00424"><title>2.3. Body Composition and Anthropometric Measures</title><p>Body mass was measured using a Micheletti (S&#x000e3;o Paulo, SP, Brazil) electronic scale and height was measured using a standard stadiometer Sanny (S&#x000e3;o Paulo, SP, Brazil), followed by body mass index (BMI) calculation. Total fat mass and fat-free mass were measured by bioimpedance (Biodynamics model 450c&#x02014;Biodynamics, Shoreline, WA, USA). This analysis was performed in the morning after participants had fasted for at least 8 h, and hydration was controlled as previously reported by de Fran&#x000e7;a et al. [<xref rid="B18-nutrients-10-00424" ref-type="bibr">18</xref>].</p></sec><sec id="sec2dot4-nutrients-10-00424"><title>2.4. Dietary Assessment</title><p>All participants were instructed to maintain their regular diet during the study. Food intake was evaluated at baseline and at the end of the study by three dietary recalls collected by trained nutritionists. Dietary data were reported on non-consecutive days (two week days and one weekend day), and were analyzed by Dietpro<sup>&#x000ae;</sup> 5.7i (Minas Gerais, MG, Brazil) software and by the United States Department of Agriculture (USDA) food composition table.</p></sec><sec id="sec2dot5-nutrients-10-00424"><title>2.5. Exercise Training</title><p>The exercise training consisted of combined aerobic and resistance exercises performed during the same session. All women performed 30 sessions over ten weeks on non-consecutive days three times per week, and all sessions lasted 50 min, including 5 min of warm-up on a treadmill, 20 min of aerobic exercise on a treadmill, 20 min of resistance exercises and 5 min of cool down exercises. The order of aerobic and resistance exercises was changed every training session. Before the exercise training intervention, all women performed a familiarization session with the treadmill and resistance exercises.</p><p>Aerobic training was performed on treadmill at a speed of 5.5 km/h, and exercise intensity was imposed only by increasing the treadmill incline. The training intensity was between ventilatory threshold 1 (VT1) and ventilatory threshold 2 (VT2), determined previously by an incremental test. The incremental test was adapted from Puga et al. [<xref rid="B19-nutrients-10-00424" ref-type="bibr">19</xref>]. Briefly, women performed a sub-maximal incremental test on treadmill at a fixed speed of 5.5 km/h and the intensity was added by increasing the treadmill incline (%). The test started with a 1% incline and was increased in increments of 1% every 2 min until the volunteers reached 85% of their predicted maximum heart rate and/or a perceived rate of exertion of 18 on the Borg Scale. The VT1 and 2 were identified based on the ventilatory equivalents for oxygen (VE/VO<sub>2</sub> ratio) and carbon dioxide (VE/VCO<sub>2</sub> ratio) responses using a gas analyzer (Cosmed Quark CPET, Rome, Italy) in accordance with Wasserman [<xref rid="B20-nutrients-10-00424" ref-type="bibr">20</xref>].</p><p>The resistance training was performed as 2 sets of 15 repetitions, with an interval of 30 s between exercises. The exercises consisted of seven exercises for large muscle groups, including 45&#x000b0; leg press, crossover seated row, bench press, pec deck, lateral pull-down, squat with fitball and abdominal exercises. The intensity of the exercises was 60%, based on the 1RM test, with load readjustments via a new test in the 5th week. The 1RM test started with a warm up that consisted of two sets of exercises at 40&#x02013;50% (5&#x02013;10 repetitions) and 60&#x02013;80% (3&#x02013;5 repetitions) of the participant&#x02019;s estimated 1RM. The test began with volunteers performing one complete repetition (eccentric and concentric phase) at maximal effort. The 1RM consisted of the workload being performed with no more than one repetition [<xref rid="B21-nutrients-10-00424" ref-type="bibr">21</xref>].</p></sec><sec id="sec2dot6-nutrients-10-00424"><title>2.6. Blood Samples Collection and Analysis</title><p>Fifteen mL blood samples were collected after an overnight fast, five days before, and 72 h after, the last exercise training session to eliminate the acute effects of the exercise. These samples were placed in EDTA or serum tubes with separator gel and then centrifuged at 3000 rpm for 15 min and stored in small tubes for future analysis.</p><p>Plasma concentrations of total cholesterol, triglycerides, high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol, uric acid and glucose were determined by enzymatic colorimetric methods. The concentration of glycated hemoglobin (HbA1c) was determined by the turbidimetry method. All analyses were performed using an automated system (Cobas Mira, Roche Instruments Inc. Bellport, NY, USA), using commercial kits (Labtest, Minas Gerais, Brazil). Very low density lipoprotein (VLDL) values were calculated using the Friedwald equation.</p><p>Human cytokines (IL-8, IL-1&#x003b2;, IL-6, TNF, IL-10 and IL-12p70) in serum samples were measured by the flow cytometry technique (FACSCantoII BD&#x02122;, San Jose, CA, USA) using a Human Inflammatory Cytokines Kit (BD&#x02122; Cytometric Bead Array (CBA), BD Biosciences, San Jose, CA, USA) according to the manufacturer&#x02019;s instructions.</p><p>The total antioxidant capacity in the plasma was evaluated by the Ferric-Ability of Plasma (FRAP) methodology and calculated from the standard trolox curve, as described by Justino et al. [<xref rid="B22-nutrients-10-00424" ref-type="bibr">22</xref>]. The activity of the superoxide dismutase enzyme (SOD) was determined based on the auto-oxidation capacity of pyrogallol. Lipid peroxidation levels were analyzed by the TBARS (thiobarbituric acid reactive substances) method, using a curve of 1,1,3,3-tetramethoxypropane (TMP) as the standard [<xref rid="B22-nutrients-10-00424" ref-type="bibr">22</xref>].</p></sec><sec id="sec2dot7-nutrients-10-00424"><title>2.7. Statistics</title><p>The results are presented as means &#x000b1; standard errors. The data distribution was analyzed using the Shapiro-Wilk test. Sample size was calculated using data from GPower 3.0.10, using an &#x003b1; value of 0.05, a &#x003b2; value of 0.15 and a power analysis of 85% with a final number of volunteers of 30 women. The two-way Analysis of Variance (ANOVA) for repeated measures was used to analyze the time (pre and post) and group (PLA and ISO) interactions with a Bonferroni post hoc test, when appropriate. Unpaired student&#x02019;s <italic>t</italic>-tests were used to compare the delta values between groups. A Pearson correlation was also performed. A <italic>p</italic>-value of &#x02264;0.05 was used for statistical significance, and all statistical analyses were performed using SPSS software version 20.0 (IBM, NewYork, NY, USA).</p></sec></sec><sec id="sec3-nutrients-10-00424"><title>3. Results</title><p>The included women had mean ages of 52.7 &#x000b1; 4.9 and 56.0 &#x000b1; 5.4 years; body masses of 64.7 &#x000b1; 2.2 and 65.4 &#x000b1; 2.1 kg; body mass indices of 26.9 &#x000b1; 0.7 and 26.4 &#x000b1; 0.8 kg/m<sup>2</sup> and fat masses of 35.4 &#x000b1; 1.1 and 35.4 &#x000b1; 1.1% in the PLA and ISO groups, respectively. There were no significant differences in any of these characteristics between groups at the beginning of the study. There were also no significant differences between pre-values (described above) and post values in body mass (65.6 &#x000b1; 2.3 kg for PLA and 64.3 &#x000b1; 2.1 kg for ISO), body mass index (26.9 &#x000b1; 0.7 8 kg/m<sup>2</sup> for PLA and 26.4 &#x000b1; 0.8 8 kg/m<sup>2</sup> for ISO), and fat mass (34.6 &#x000b1; 1.2 kg for PLA and 35.5 &#x000b1; 1.3 kg for ISO).</p><p>The volunteers exercised at an average intensity of 5 &#x000b1; 5% (treadmill inclination), a rate of perceived exertion of 16 &#x000b1; 2 and a heart rate zone of 158 &#x000b1; 16 bpm. There were no significant differences in dietary protein, fat or carbohydrate ingestion evaluated by food recall during the 10-week intervention between the groups.</p><p>Vitamins A, C and D, which are considered exogenous non-enzymatic antioxidants, were also evaluated by food recall and were not different between groups or moments during the intervention. The consumption of vitamin A in the PLA group was 224.82 &#x000b1; 368.28 mg pre-intervention and 217.82 &#x000b1; 376.82 mg post-intervention, and in the ISO group, 147.57 &#x000b1; 128.53 mg pre-intervention and 113.08 &#x000b1; 60.05 mg post-intervention. Vitamin C consumption in PLA was 224.82 &#x000b1; 368.28 mg pre-intervention and 217.82 &#x000b1; 376.82 post-intervention, and in the ISO group, 147.57 &#x000b1; 128.53 pre-intervention and 113.08 &#x000b1; 60.05 post-intervention. The intake of vitamin D in the PLA group was 46.21 &#x000b1; 33.11 mg pre-intervention and 44.69 &#x000b1; 31.36 mg post-intervention, and in the ISO group, 49.91 &#x000b1; 42.76 mg pre-intervention and 51.48 &#x000b1; 40.16 mg post-intervention. There were also no differences between moments or groups in carbohydrate (pre: 221.02 &#x000b1; 45.87 g and post: 204.65 &#x000b1; 63.85 g for PLA group and pre: 203.98 &#x000b1; 42.21 and post: 193.17 &#x000b1; 48.98 g for ISO group), protein (pre: 67.25 &#x000b1; 16.83 g and post: 60.84 &#x000b1; 20.44 g for PLA group and pre: 61.61 &#x000b1; 16.40 g and post: 56.97 &#x000b1; 15.63 g for ISO group) lipid (pre: 80.14 &#x000b1; 26.34 g and post: 68.05 &#x000b1; 17.85 for PLA group and pre: 64.90 &#x000b1; 17.13 g and post: 61.42 &#x000b1; 18.83 for ISO group) or fiber intake (pre: 15.97 &#x000b1; 6.24 g and post: 12.79 &#x000b1; 4.94 g for PLA group and pre: 15.49 &#x000b1; 6.04 g and post: 13.50 &#x000b1; 4.94 g for ISO group).</p><p>The fasting lipid profile, glucose, glycated hemoglobin (HbA1C) and uric acid levels were analyzed before and after the 10-week intervention in both groups and are shown in <xref ref-type="table" rid="nutrients-10-00424-t001">Table 1</xref>. No significant differences were found for any of the variables for time or group. Although total cholesterol levels increased after the intervention in both groups with a significant effect of time (<italic>p</italic> = 0.04), no interaction between the groups was found (group * moment) (<italic>p</italic> = 0.07). The delta values (post&#x02013;pre values) were also not different between groups.</p><p><xref ref-type="table" rid="nutrients-10-00424-t002">Table 2</xref> shows the levels of inflammatory and oxidative stresses markers analyzed before and after the 10-week intervention in both groups. Among the possible cytokines to be analyzed in the Kit (IL-8, IL-1&#x003b2;, IL-6, TNF, IL-10 and Il-12p70), only interleukin-6 (IL-6) and interleukin-8 (IL-8) were read-sensitive. We found no differences between time or group in any of the inflammatory markers or oxidative stress. However, IL-8 concentrations increased after the intervention in both groups with a significant effect of time (<italic>p</italic> = 0.001), but no interaction between the groups was found (group * moment) (<italic>p</italic> = 0.55). The deltas of the variables (post&#x02013;pre values) were not different between groups.</p><p>We found a significant positive Pearson correlation between the TBARS and FRAP variables (<italic>r</italic> = 1.0, <italic>p</italic> &#x0003c; 0.0001) in both groups after the intervention. A significant negative correlation between IL-8 and FRAP (<italic>r</italic> = 0.76, <italic>p</italic> = 0.0009) and between IL-8 and TBARS (r = 0.76; <italic>p</italic> = 0.0009) was observed only in the PLA group after the intervention. No other significant correlations were found among all the other variables analyzed. No changes were found to be significant between the groups.</p></sec><sec id="sec4-nutrients-10-00424"><title>4. Discussion</title><p>The present study examined the effect of isoflavone supplementation in addition to a combined aerobic and resistance training program on lipid levels, inflammatory markers and oxidative stress in postmenopausal women. Our results indicate that the supplementation of isoflavones when combined with exercise training does not promote additive changes in any of the inflammatory markers or oxidative stress markers measured in postmenopausal women. However, combined training was effective in reducing total cholesterol and increasing IL-8 levels in non-obese, postmenopausal women.</p><p>The increase in IL-6 concentration caused by acute exercise (after one exercise session) is believed to inhibit the release of pro-inflammatory agents, such as TNF-&#x003b1;, and stimulate immune cells to produce anti-inflammatory cytokines by promoting a chronic anti-inflammatory effect, when exercise is practiced regularly [<xref rid="B7-nutrients-10-00424" ref-type="bibr">7</xref>]. In our study, we found no significant difference in serum IL-6 concentration after the intervention in either group. Lebon et al. [<xref rid="B11-nutrients-10-00424" ref-type="bibr">11</xref>] that also found no change in IL-6 concentration after 6 months of supplementation of 70 mg of isoflavones and combined exercise in healthy postmenopausal women. Likewise, Ho et al. [<xref rid="B23-nutrients-10-00424" ref-type="bibr">23</xref>] did not observe a change in IL-6 after performance of any of the types of exercises studied, but TNF-&#x003b1; levels decreased more sharply after 12 weeks in a group that performed combined moderate intensity exercise compared to groups that performed isolated aerobic and resistance exercises. On the other hand, the study conducted by Forti et al. [<xref rid="B24-nutrients-10-00424" ref-type="bibr">24</xref>] found reductions in IL-6 concentrations in healthy young participants. This study showed that nine weeks of resistance training increased IL-8 and decreased IL-6, which demonstrated that this kind of training can have anti-inflammatory effects in healthy, young people.</p><p>Balducci et al. [<xref rid="B25-nutrients-10-00424" ref-type="bibr">25</xref>] showed that, in people with metabolic syndrome and type 2 diabetes, high-intensity training, performed over a 12-month period, reduced IL-6 concentrations in patients who performed combined aerobic and resistance exercises. These results are not in agreement with our results, and we believe that those who already have elevated levels of inflammatory markers are more likely to see improvements after an exercise training program. Although postmenopausal women may present higher concentrations of IL-6 compared to premenopausal women [<xref rid="B26-nutrients-10-00424" ref-type="bibr">26</xref>], our volunteers were healthy and had low baseline serum levels of IL-6, which may explain the absence of changes after 10 weeks of study.</p><p>IL-8, when released by skeletal muscle through exercise, acts as an important angiogenic factor which is separate from its pro-inflammatory capacity [<xref rid="B7-nutrients-10-00424" ref-type="bibr">7</xref>]. In a recent study, Forti et al. [<xref rid="B24-nutrients-10-00424" ref-type="bibr">24</xref>] analyzed different intensities of resistance exercise training in healthy young participants for 9 weeks and found an increase in IL-8 concentrations in participants in a high-intensity exercise group and in low-resistance training with maximal effort group, but not in a low intensity with low effort exercise group. This response was associated with adaptation to intense exercise and may be responsible for the induction of angiogenesis. Alternatively, Izzicupo et al. [<xref rid="B27-nutrients-10-00424" ref-type="bibr">27</xref>] found a reduction in serum IL-8 levels after a 13-week moderate intensity walking program in postmenopausal women. Although the authors found a reduction in IL-8 concentrations rather than an increase, the angiogenic properties found in the serum improved after the study [<xref rid="B27-nutrients-10-00424" ref-type="bibr">27</xref>]. In our study, we observed a significant increase in serum IL-8 in both groups after the 10-week intervention, but there was no difference between groups. Independent of isoflavone supplementation, combined exercise training, with the complementary effects of both exercise components (aerobic and resistance) at a moderate intensity, increases IL-8 levels and this may be related to the induction of angiogenesis, since skeletal muscle, with stimulation from exercise, may induce the production of IL-8 and increase the expression of its receptor responsible for angiogenesis [<xref rid="B7-nutrients-10-00424" ref-type="bibr">7</xref>].</p><p>The period after menopause also contributes to an imbalance in the pro and antioxidant systems [<xref rid="B2-nutrients-10-00424" ref-type="bibr">2</xref>]. In fact, acute exercise can increase reactive oxygen species production, but chronic exercise training contributes to an improvement in antioxidant defenses and consequently, reduces the state of oxidative stress [<xref rid="B28-nutrients-10-00424" ref-type="bibr">28</xref>]. One study, using a combined exercise training intervention over 12 weeks in women with fibromyalgia, found a reduction in plasma TBARS and an increase in serum levels of the antioxidant enzyme, catalase [<xref rid="B5-nutrients-10-00424" ref-type="bibr">5</xref>]. Similarly, the consumption of 100 mg of isoflavones (with no exercise intervention) per day may reduce the concentration of the reactive species, malondialdehyde [<xref rid="B3-nutrients-10-00424" ref-type="bibr">3</xref>], the intercellular adhesion molecule (ICAM-1) and E-selectin, in postmenopausal women [<xref rid="B29-nutrients-10-00424" ref-type="bibr">29</xref>]. So, to our knowledge, this is the first study to investigate the association of isoflavones with a combined exercise program for oxidative stress markers in postmenopausal women, and our results indicate that 100 mg of isoflavones in addition to moderate combined exercise does not alter these markers after 10 weeks in this population. We believe that a longer time frame may be necessary to detect the effects of this type of intervention on oxidative stress variables in healthy postmenopausal women.</p><p>Maintaining a healthy lipid profile is very important, since elevated levels of total cholesterol are directly related to cardiovascular disease [<xref rid="B30-nutrients-10-00424" ref-type="bibr">30</xref>]. Mann et al. [<xref rid="B31-nutrients-10-00424" ref-type="bibr">31</xref>] reviewed the effects of different types of exercise training on cholesterol levels and concluded that resistance training may complement the effects of aerobic training, although there is limited literature comparing the three types of exercises (aerobic, resistance and combined exercises). Likewise, Park et al. [<xref rid="B6-nutrients-10-00424" ref-type="bibr">6</xref>], showed that combined exercise may reduce total cholesterol in obese women more than in aerobic exercise alone. Therefore, the reduction of total cholesterol found in both groups in our study is in agreement with previous clinical trials and indicates that combined physical exercise may be an alternative for reducing this risk factor in postmenopausal women.</p><p>On the other hand, the effect of isoflavone consumption on cholesterol levels is still controversial. According to a meta-analysis by Zhan and Ho [<xref rid="B32-nutrients-10-00424" ref-type="bibr">32</xref>], isoflavone supplementation is associated with improvements in the lipid profile, although other authors have not found the same isoflavone effect on lipid parameters [<xref rid="B33-nutrients-10-00424" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-10-00424" ref-type="bibr">34</xref>]. When isoflavones are taken in combination with exercise training, the effect on the lipid profile remains inconclusive. Some authors did not observe the additive effects of these compounds and exercise training on lipid variables [<xref rid="B35-nutrients-10-00424" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-10-00424" ref-type="bibr">36</xref>]. However, Wu et al. [<xref rid="B12-nutrients-10-00424" ref-type="bibr">12</xref>] found an increase in HDL after 24 weeks of 75 mg of isoflavones combined with aerobic exercise and concluded that some benefits of this association can be depend on the production of equol, a specific metabolite of daidzein produced by bacteria in the gut. This metabolite is not found in soya, but is formed by intestinal flora in 30&#x02013;50% of individuals after consumption of these compounds [<xref rid="B37-nutrients-10-00424" ref-type="bibr">37</xref>]. In the present study, we found no interaction between group or time for total cholesterol, and this suggests that isoflavone supplementation had no additive beneficial effects on exercise-mediated responses. The mechanisms behind a possible lack of interaction between exercise and isoflavone consumption are still unclear.</p><p>There were some limitations in the present study. The study was conducted in generally healthy, non-obese women; therefore, the results might not be applicable to other groups receiving treatment with higher potency medication or for longer than 10 weeks. It is important to note also that this result is applicable only for isoflavone supplementation and may not be extrapolated to isoflavone consumption from natural and regular food. Other limitations were the absence of an evaluation of isoflavone levels in the urine to detect how much soy protein was actually absorbed, as well as the 10-week intervention, which is a biologically acceptable time frame for a clinical study but may have been relatively short for detecting the effects of isoflavone supplementation associated with combined exercise. More studies are needed with larger numbers of participants and with patients with dyslipidemia, obesity or with high oxidative stress levels or inflammatory states to investigate the effects of these interventions.</p></sec><sec id="sec5-nutrients-10-00424"><title>5. Conclusions</title><p>Isoflavone supplementation did not promote additive or independent effects compared to the combination of aerobic and resistance exercises alone on the lipid profile and on inflammatory and oxidative stress markers in non-obese postmenopausal women. However, this exercise training program increased IL-8 levels independent of the isoflavone supplementation and appears to be effective for reducing total cholesterol in this population.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was funded by the Minas Gerais State Research Foundation (FAPEMIG) (APQ-00750-14) and the National Council for Scientific and Technological Development (CNPq) (456443/2014-2) e CNPq (794078/2013). FSE is gran recipient of CNPq (308965/2015-9).</p></ack><notes><title>Author Contributions</title><p>J.S.G. participated in collection and analysis of the data, performed statistical analysis, and wrote the manuscript; J.G.C. participated in collection and analysis of the data, performed statistical analysis and contributed with the revision of the manuscript; J.P.d.C.-J., A.C.A.M.P., E.A.T., A.V.d.S. and L.G.P. participated in collection and analysis of the data; F.S.E. participated in the study design and contributed with the revision of the manuscript; E.P.d.O. contributed with food recall analysis, elaboration of the discussion and with the revision of the manuscript; S.E. contributed with manuscript and English review; G.M.P. contributed with the study design, data collection and analysis, statistical analysis, and with manuscript elaboration and review. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-10-00424"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvehus</surname><given-names>M.</given-names></name><name><surname>Simonyte</surname><given-names>K.</given-names></name><name><surname>Andersson</surname><given-names>T.</given-names></name><name><surname>S&#x000f6;derstr&#x000f6;m</surname><given-names>I.</given-names></name><name><surname>Bur&#x000e9;n</surname><given-names>J.</given-names></name><name><surname>Rask</surname><given-names>E.</given-names></name><name><surname>Mattsson</surname><given-names>C.</given-names></name><name><surname>Olsson</surname><given-names>T.</given-names></name></person-group><article-title>Adipose tissue IL-8 is increased in normal weight women after menopause and reduced after gastric bypass surgery in obese women: IL-8 levels in normal weight and obese women</article-title><source>Clin. Endocrinol.</source><year>2012</year><volume>77</volume><fpage>684</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2011.04322.x</pub-id><pub-id pub-id-type="pmid">22168600</pub-id></element-citation></ref><ref id="B2-nutrients-10-00424"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Signorelli</surname><given-names>S.S.</given-names></name><name><surname>Neri</surname><given-names>S.</given-names></name><name><surname>Sciacchitano</surname><given-names>S.</given-names></name><name><surname>Pino</surname><given-names>L.D.</given-names></name><name><surname>Costa</surname><given-names>M.P.</given-names></name><name><surname>Marchese</surname><given-names>G.</given-names></name><name><surname>Celotta</surname><given-names>G.</given-names></name><name><surname>Cassibba</surname><given-names>N.</given-names></name><name><surname>Pennisi</surname><given-names>G.</given-names></name><name><surname>Caschetto</surname><given-names>S.</given-names></name></person-group><article-title>Behaviour of some indicators of oxidative stress in postmenopausal and fertile women</article-title><source>Maturitas</source><year>2006</year><volume>53</volume><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2005.03.001</pub-id><pub-id pub-id-type="pmid">16325025</pub-id></element-citation></ref><ref id="B3-nutrients-10-00424"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pusparini</surname></name><name><surname>Dharma</surname><given-names>R.</given-names></name><name><surname>Suyatna</surname><given-names>F.D.</given-names></name><name><surname>Mansyur</surname><given-names>M.</given-names></name><name><surname>Hidajat</surname><given-names>A.</given-names></name></person-group><article-title>Effect of soy isoflavone supplementation on vascular endothelial function and oxidative stress in postmenopausal women: A community randomized controlled trial</article-title><source>Asia Pac. J. Clin. Nutr.</source><year>2013</year><volume>22</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.6133/apjcn.2013.22.3.13</pub-id><pub-id pub-id-type="pmid">23945405</pub-id></element-citation></ref><ref id="B4-nutrients-10-00424"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>M.</given-names></name><name><surname>Bishop</surname><given-names>N.C.</given-names></name><name><surname>Stensel</surname><given-names>D.J.</given-names></name><name><surname>Lindley</surname><given-names>M.R.</given-names></name><name><surname>Mastana</surname><given-names>S.S.</given-names></name><name><surname>Nimmo</surname><given-names>M.A.</given-names></name></person-group><article-title>The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease</article-title><source>Nat. Rev. Immunol.</source><year>2011</year><volume>11</volume><fpage>607</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1038/nri3041</pub-id><pub-id pub-id-type="pmid">21818123</pub-id></element-citation></ref><ref id="B5-nutrients-10-00424"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sar&#x00131;fak&#x00131;o&#x0011f;lu</surname><given-names>B.</given-names></name><name><surname>G&#x000fc;zelant</surname><given-names>A.Y.</given-names></name><name><surname>G&#x000fc;zel</surname><given-names>E.&#x000c7;.</given-names></name><name><surname>G&#x000fc;zel</surname><given-names>S.</given-names></name><name><surname>K&#x00131;z&#x00131;ler</surname><given-names>A.R.</given-names></name></person-group><article-title>Effects of 12-week combined exercise therapy on oxidative stress in female fibromyalgia patients</article-title><source>Rheumatol. Int.</source><year>2014</year><volume>34</volume><fpage>1361</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1007/s00296-014-2978-2</pub-id><pub-id pub-id-type="pmid">24610539</pub-id></element-citation></ref><ref id="B6-nutrients-10-00424"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.-K.</given-names></name><name><surname>Park</surname><given-names>J.-H.</given-names></name><name><surname>Kwon</surname><given-names>Y.-C.</given-names></name><name><surname>Kim</surname><given-names>H.-S.</given-names></name><name><surname>Yoon</surname><given-names>M.-S.</given-names></name><name><surname>Park</surname><given-names>H.-T.</given-names></name></person-group><article-title>The effect of combined aerobic and resistance exercise training on abdominal fat in obese middle-aged women</article-title><source>J. Physiol. Anthropol. Appl. Hum. Sci.</source><year>2003</year><volume>22</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.2114/jpa.22.129</pub-id></element-citation></ref><ref id="B7-nutrients-10-00424"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>A.R.</given-names></name><name><surname>Pedersen</surname><given-names>B.K.</given-names></name></person-group><article-title>The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15</article-title><source>Appl. Physiol. Nutr. MeTable</source><year>2007</year><volume>32</volume><fpage>833</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1139/H07-054</pub-id><pub-id pub-id-type="pmid">18059606</pub-id></element-citation></ref><ref id="B8-nutrients-10-00424"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrelli</surname><given-names>F.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title>Alternative and complementary therapies for the menopause</article-title><source>Maturitas</source><year>2010</year><volume>66</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2010.05.010</pub-id><pub-id pub-id-type="pmid">20580501</pub-id></element-citation></ref><ref id="B9-nutrients-10-00424"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiSilvestro</surname><given-names>R.A.</given-names></name><name><surname>Goodman</surname><given-names>J.</given-names></name><name><surname>Dy</surname><given-names>E.</given-names></name><name><surname>LaValle</surname><given-names>G.</given-names></name></person-group><article-title>Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors</article-title><source>Breast Cancer Res. Treat.</source><year>2005</year><volume>89</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1007/s10549-004-2227-6</pub-id><pub-id pub-id-type="pmid">15754123</pub-id></element-citation></ref><ref id="B10-nutrients-10-00424"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>H.Y.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>J.M.</given-names></name><name><surname>Kim</surname><given-names>D.-Y.</given-names></name><name><surname>Ann</surname><given-names>E.-S.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name></person-group><article-title>A combination of soy isoflavone supplementation and exercise improves lipid profiles and protects antioxidant defense-systems against exercise-induced oxidative stress in ovariectomized rats</article-title><source>Biofactors</source><year>2007</year><volume>29</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1002/biof.5520290402</pub-id><pub-id pub-id-type="pmid">18057549</pub-id></element-citation></ref><ref id="B11-nutrients-10-00424"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebon</surname><given-names>J.</given-names></name><name><surname>Riesco</surname><given-names>E.</given-names></name><name><surname>Tessier</surname><given-names>D.</given-names></name><name><surname>Dionne</surname><given-names>I.J.</given-names></name></person-group><article-title>Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: A randomized controlled trial</article-title><source>Menopause</source><year>2014</year><volume>21</volume><fpage>869</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1097/GME.0000000000000177</pub-id><pub-id pub-id-type="pmid">24378766</pub-id></element-citation></ref><ref id="B12-nutrients-10-00424"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Oka</surname><given-names>J.</given-names></name><name><surname>Higuchi</surname><given-names>M.</given-names></name><name><surname>Tabata</surname><given-names>I.</given-names></name><name><surname>Toda</surname><given-names>T.</given-names></name><name><surname>Fujioka</surname><given-names>M.</given-names></name><name><surname>Fuku</surname><given-names>N.</given-names></name><name><surname>Teramoto</surname><given-names>T.</given-names></name><name><surname>Okuhira</surname><given-names>T.</given-names></name><name><surname>Ueno</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: A randomized placebo-controlled trial</article-title><source>Metabolism</source><year>2006</year><volume>55</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2005.10.002</pub-id><pub-id pub-id-type="pmid">16546471</pub-id></element-citation></ref><ref id="B13-nutrients-10-00424"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilibeck</surname><given-names>P.D.</given-names></name><name><surname>Vatanparast</surname><given-names>H.</given-names></name><name><surname>Pierson</surname><given-names>R.</given-names></name><name><surname>Case</surname><given-names>A.</given-names></name><name><surname>Olatunbosun</surname><given-names>O.</given-names></name><name><surname>Whiting</surname><given-names>S.J.</given-names></name><name><surname>Beck</surname><given-names>T.J.</given-names></name><name><surname>Pahwa</surname><given-names>P.</given-names></name><name><surname>Biem</surname><given-names>H.J.</given-names></name></person-group><article-title>Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: A randomized clinical trial</article-title><source>J. Bone Miner. Res.</source><year>2013</year><volume>28</volume><fpage>780</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1002/jbmr.1815</pub-id><pub-id pub-id-type="pmid">23165609</pub-id></element-citation></ref><ref id="B14-nutrients-10-00424"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Murphy</surname><given-names>P.A.</given-names></name></person-group><article-title>Isoflavone content in commercial soybean foods</article-title><source>J. Agric. Food Chem.</source><year>1994</year><volume>42</volume><fpage>1666</fpage><lpage>1673</lpage><pub-id pub-id-type="doi">10.1021/jf00044a016</pub-id></element-citation></ref><ref id="B15-nutrients-10-00424"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anupongsanugool</surname><given-names>E.</given-names></name><name><surname>Teekachunhatean</surname><given-names>S.</given-names></name><name><surname>Rojanasthien</surname><given-names>N.</given-names></name><name><surname>Pongsatha</surname><given-names>S.</given-names></name><name><surname>Sangdee</surname><given-names>C.</given-names></name></person-group><article-title>Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women</article-title><source>BMC Clin. Pharmacol.</source><year>2005</year><volume>5</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6904-5-2</pub-id><pub-id pub-id-type="pmid">15743537</pub-id></element-citation></ref><ref id="B16-nutrients-10-00424"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><name><surname>Sobue</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Miura</surname><given-names>T.</given-names></name><name><surname>Arai</surname><given-names>Y.</given-names></name><name><surname>Mazur</surname><given-names>W.</given-names></name><name><surname>W&#x000e4;h&#x000e4;l&#x000e4;</surname><given-names>K.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name></person-group><article-title>Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako)</article-title><source>J. Nutr.</source><year>1998</year><volume>128</volume><fpage>1710</fpage><lpage>1715</lpage><pub-id pub-id-type="doi">10.1093/jn/128.10.1710</pub-id><pub-id pub-id-type="pmid">9772140</pub-id></element-citation></ref><ref id="B17-nutrients-10-00424"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>G.E.</given-names></name><name><surname>Joannou</surname><given-names>G.E.</given-names></name><name><surname>Reeder</surname><given-names>A.Y.</given-names></name><name><surname>Nelson</surname><given-names>C.</given-names></name><name><surname>Waring</surname><given-names>M.A.</given-names></name></person-group><article-title>The variable metabolic response to dietary isoflavones in humans</article-title><source>Proc. Soc. Exp. Biol. Med.</source><year>1995</year><volume>208</volume><fpage>40</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.3181/00379727-208-43829</pub-id><pub-id pub-id-type="pmid">7892293</pub-id></element-citation></ref><ref id="B18-nutrients-10-00424"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Fran&#x000e7;a</surname><given-names>N.A.G.</given-names></name><name><surname>Callegari</surname><given-names>A.</given-names></name><name><surname>Gondo</surname><given-names>F.F.</given-names></name><name><surname>Corrente</surname><given-names>J.E.</given-names></name><name><surname>Mclellan</surname><given-names>K.C.P.</given-names></name><name><surname>Burini</surname><given-names>R.C.</given-names></name><name><surname>de Oliveira</surname><given-names>E.P.</given-names></name></person-group><article-title>Higher dietary quality and muscle mass decrease the odds of low phase angle in bioelectrical impedance analysis in Brazilian individuals: Dietary quality, muscle mass and phase angle</article-title><source>Nutr. Diet.</source><year>2016</year><volume>73</volume><fpage>474</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1111/1747-0080.12267</pub-id></element-citation></ref><ref id="B19-nutrients-10-00424"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puga</surname><given-names>G.M.</given-names></name><name><surname>Novais</surname><given-names>I.D.P.</given-names></name><name><surname>Katsanos</surname><given-names>C.S.</given-names></name><name><surname>Zanesco</surname><given-names>A.</given-names></name></person-group><article-title>Combined effects of aerobic exercise and L-arginine ingestion on blood pressure in normotensive postmenopausal women: A crossover study</article-title><source>Life Sci.</source><year>2016</year><volume>151</volume><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2016.02.091</pub-id><pub-id pub-id-type="pmid">26972606</pub-id></element-citation></ref><ref id="B20-nutrients-10-00424"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>K.</given-names></name></person-group><article-title>The anaerobic threshold measurement to evaluate exercise performance</article-title><source>Am. Rev. Respir. Dis.</source><year>1984</year><volume>129</volume><fpage>S35</fpage><lpage>S40</lpage><pub-id pub-id-type="doi">10.1164/arrd.1984.129.2P2.S35</pub-id><pub-id pub-id-type="pmid">6421216</pub-id></element-citation></ref><ref id="B21-nutrients-10-00424"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>W.J.</given-names></name><name><surname>Gordon</surname><given-names>S.E.</given-names></name><name><surname>Fleck</surname><given-names>S.J.</given-names></name><name><surname>Marchitelli</surname><given-names>L.J.</given-names></name><name><surname>Mello</surname><given-names>R.</given-names></name><name><surname>Dziados</surname><given-names>J.E.</given-names></name><name><surname>Friedl</surname><given-names>K.</given-names></name><name><surname>Harman</surname><given-names>E.</given-names></name><name><surname>Maresh</surname><given-names>C.</given-names></name><name><surname>Fry</surname><given-names>A.C.</given-names></name></person-group><article-title>Endogenous anabolic hormonal and growth factor responses to heavy resistance exercise in males and females</article-title><source>Int. J. Sports Med.</source><year>1991</year><volume>12</volume><fpage>228</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1055/s-2007-1024673</pub-id><pub-id pub-id-type="pmid">1860749</pub-id></element-citation></ref><ref id="B22-nutrients-10-00424"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justino</surname><given-names>A.B.</given-names></name><name><surname>Pereira</surname><given-names>M.N.</given-names></name><name><surname>Peixoto</surname><given-names>L.G.</given-names></name><name><surname>Vilela</surname><given-names>D.D.</given-names></name><name><surname>Caixeta</surname><given-names>D.C.</given-names></name><name><surname>de Souza</surname><given-names>A.V.</given-names></name><name><surname>Teixeira</surname><given-names>R.R.</given-names></name><name><surname>Silva</surname><given-names>H.C.G.</given-names></name><name><surname>de Moura</surname><given-names>F.B.R.</given-names></name><name><surname>Moraes</surname><given-names>I.B.</given-names></name><etal/></person-group><article-title>Hepatoprotective Properties of a Polyphenol-Enriched Fraction from Annona crassiflora Mart. Fruit Peel against Diabetes-Induced Oxidative and Nitrosative Stress</article-title><source>J. Agric. Food Chem.</source><year>2017</year><volume>65</volume><fpage>4428</fpage><lpage>4438</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b01355</pub-id><pub-id pub-id-type="pmid">28514152</pub-id></element-citation></ref><ref id="B23-nutrients-10-00424"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>S.S.</given-names></name><name><surname>Dhaliwal</surname><given-names>S.S.</given-names></name><name><surname>Hills</surname><given-names>A.P.</given-names></name><name><surname>Pal</surname><given-names>S.</given-names></name></person-group><article-title>Effects of Chronic Exercise Training on Inflammatory Markers in Australian Overweight and Obese Individuals in a Randomized Controlled Trial</article-title><source>Inflammation</source><year>2013</year><volume>36</volume><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1007/s10753-012-9584-9</pub-id><pub-id pub-id-type="pmid">23250821</pub-id></element-citation></ref><ref id="B24-nutrients-10-00424"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forti</surname><given-names>L.N.</given-names></name><name><surname>Van Roie</surname><given-names>E.</given-names></name><name><surname>Njemini</surname><given-names>R.</given-names></name><name><surname>Coudyzer</surname><given-names>W.</given-names></name><name><surname>Beyer</surname><given-names>I.</given-names></name><name><surname>Delecluse</surname><given-names>C.</given-names></name><name><surname>Bautmans</surname><given-names>I.</given-names></name></person-group><article-title>Effects of resistance training at different loads on inflammatory markers in young adults</article-title><source>Eur. J. Appl. Physiol.</source><year>2017</year><volume>117</volume><fpage>511</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1007/s00421-017-3548-6</pub-id><pub-id pub-id-type="pmid">28168555</pub-id></element-citation></ref><ref id="B25-nutrients-10-00424"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balducci</surname><given-names>S.</given-names></name><name><surname>Zanuso</surname><given-names>S.</given-names></name><name><surname>Nicolucci</surname><given-names>A.</given-names></name><name><surname>Fernando</surname><given-names>F.</given-names></name><name><surname>Cavallo</surname><given-names>S.</given-names></name><name><surname>Cardelli</surname><given-names>P.</given-names></name><name><surname>Fallucca</surname><given-names>S.</given-names></name><name><surname>Alessi</surname><given-names>E.</given-names></name><name><surname>Letizia</surname><given-names>C.</given-names></name><name><surname>Jimenez</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2010</year><volume>20</volume><fpage>608</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2009.04.015</pub-id><pub-id pub-id-type="pmid">19695853</pub-id></element-citation></ref><ref id="B26-nutrients-10-00424"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>O.Y.</given-names></name><name><surname>Chae</surname><given-names>J.S.</given-names></name><name><surname>Paik</surname><given-names>J.K.</given-names></name><name><surname>Seo</surname><given-names>H.S.</given-names></name><name><surname>Jang</surname><given-names>Y.</given-names></name><name><surname>Cavaillon</surname><given-names>J.-M.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name></person-group><article-title>Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women</article-title><source>AGE</source><year>2012</year><volume>34</volume><fpage>415</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1007/s11357-011-9244-2</pub-id><pub-id pub-id-type="pmid">21487705</pub-id></element-citation></ref><ref id="B27-nutrients-10-00424"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izzicupo</surname><given-names>P.</given-names></name><name><surname>D&#x02019;Amico</surname><given-names>M.A.</given-names></name><name><surname>Di Blasio</surname><given-names>A.</given-names></name><name><surname>Napolitano</surname><given-names>G.</given-names></name><name><surname>Nakamura</surname><given-names>F.Y.</given-names></name><name><surname>Di Baldassarre</surname><given-names>A.</given-names></name><name><surname>Ghinassi</surname><given-names>B.</given-names></name></person-group><article-title>Aerobic Training Improves Angiogenic Potential Independently of Vascular Endothelial Growth Factor Modifications in Postmenopausal Women</article-title><source>Front. Endocrinol.</source><year>2017</year><volume>8</volume><fpage>363</fpage><pub-id pub-id-type="doi">10.3389/fendo.2017.00363</pub-id><pub-id pub-id-type="pmid">29312152</pub-id></element-citation></ref><ref id="B28-nutrients-10-00424"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>E.C.</given-names></name><name><surname>Silva</surname><given-names>A.N.</given-names></name><name><surname>de Oliveira</surname><given-names>M.R.</given-names></name></person-group><article-title>Oxidants, Antioxidants, and the Beneficial Roles of Exercise-Induced Production of Reactive Species</article-title><source>Oxid. Med. Cell. Longev.</source><year>2012</year><volume>2012</volume><fpage>756132</fpage><pub-id pub-id-type="doi">10.1155/2012/756132</pub-id><pub-id pub-id-type="pmid">22701757</pub-id></element-citation></ref><ref id="B29-nutrients-10-00424"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.-M.</given-names></name><name><surname>Ho</surname><given-names>S.C.</given-names></name><name><surname>Chen</surname><given-names>Y.-M.</given-names></name><name><surname>Woo</surname><given-names>J.</given-names></name></person-group><article-title>Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: A 6-month randomized controlled trial among postmenopausal women</article-title><source>J. Hypertens.</source><year>2013</year><volume>31</volume><fpage>384</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e32835c0905</pub-id><pub-id pub-id-type="pmid">23203140</pub-id></element-citation></ref><ref id="B30-nutrients-10-00424"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taleb-Belkadi</surname><given-names>O.</given-names></name><name><surname>Chaib</surname><given-names>H.</given-names></name><name><surname>Zemour</surname><given-names>L.</given-names></name><name><surname>Fatah</surname><given-names>A.</given-names></name><name><surname>Chafi</surname><given-names>B.</given-names></name><name><surname>Mekki</surname><given-names>K.</given-names></name></person-group><article-title>Lipid profile, inflammation, and oxidative status in peri- and postmenopausal women</article-title><source>Gynecol. Endocrinol.</source><year>2016</year><volume>32</volume><fpage>982</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1080/09513590.2016.1214257</pub-id><pub-id pub-id-type="pmid">27558905</pub-id></element-citation></ref><ref id="B31-nutrients-10-00424"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>S.</given-names></name><name><surname>Beedie</surname><given-names>C.</given-names></name><name><surname>Jimenez</surname><given-names>A.</given-names></name></person-group><article-title>Differential Effects of Aerobic Exercise, Resistance Training and Combined Exercise Modalities on Cholesterol and the Lipid Profile: Review, Synthesis and Recommendations</article-title><source>Sports Med.</source><year>2014</year><volume>44</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1007/s40279-013-0110-5</pub-id><pub-id pub-id-type="pmid">24174305</pub-id></element-citation></ref><ref id="B32-nutrients-10-00424"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>S.</given-names></name><name><surname>Ho</surname><given-names>S.C.</given-names></name></person-group><article-title>Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile</article-title><source>Am. J. Clin. Nutr.</source><year>2005</year><volume>81</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1093/ajcn.81.2.397</pub-id><pub-id pub-id-type="pmid">15699227</pub-id></element-citation></ref><ref id="B33-nutrients-10-00424"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios</surname><given-names>D.R.A.</given-names></name><name><surname>Rodrigues</surname><given-names>E.T.</given-names></name><name><surname>Cardoso</surname><given-names>A.P.Z.</given-names></name><name><surname>Montes</surname><given-names>M.B.A.</given-names></name><name><surname>Franceschini</surname><given-names>S.A.</given-names></name><name><surname>Toloi</surname><given-names>M.R.T.</given-names></name></person-group><article-title>Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women</article-title><source>Nutrition</source><year>2008</year><volume>24</volume><fpage>1153</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2008.06.030</pub-id><pub-id pub-id-type="pmid">18842392</pub-id></element-citation></ref><ref id="B34-nutrients-10-00424"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>A.</given-names></name><name><surname>De la Maza</surname><given-names>M.P.</given-names></name><name><surname>Hirsch</surname><given-names>S.</given-names></name><name><surname>Valladares</surname><given-names>L.</given-names></name></person-group><article-title>Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women</article-title><source>Maturitas</source><year>2006</year><volume>54</volume><fpage>270</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2005.12.002</pub-id><pub-id pub-id-type="pmid">16414215</pub-id></element-citation></ref><ref id="B35-nutrients-10-00424"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maesta</surname><given-names>N.</given-names></name><name><surname>Nahas</surname><given-names>E.A.P.</given-names></name><name><surname>Nahas-Neto</surname><given-names>J.</given-names></name><name><surname>Orsatti</surname><given-names>F.L.</given-names></name><name><surname>Fernandes</surname><given-names>C.E.</given-names></name><name><surname>Traiman</surname><given-names>P.</given-names></name><name><surname>Burini</surname><given-names>R.C.</given-names></name></person-group><article-title>Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women</article-title><source>Maturitas</source><year>2007</year><volume>56</volume><fpage>350</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2006.10.001</pub-id><pub-id pub-id-type="pmid">17084566</pub-id></element-citation></ref><ref id="B36-nutrients-10-00424"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choquette</surname><given-names>S.</given-names></name><name><surname>Riesco</surname><given-names>&#x000c9;.</given-names></name><name><surname>Cormier</surname><given-names>&#x000c9;.</given-names></name><name><surname>Dion</surname><given-names>T.</given-names></name><name><surname>Aubertin-Leheudre</surname><given-names>M.</given-names></name><name><surname>Dionne</surname><given-names>I.J.</given-names></name></person-group><article-title>Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: A 6-month double-blind controlled trial</article-title><source>Br. J. Nutr.</source><year>2011</year><volume>105</volume><fpage>1199</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1017/S0007114510004897</pub-id><pub-id pub-id-type="pmid">21205384</pub-id></element-citation></ref><ref id="B37-nutrients-10-00424"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setchell</surname><given-names>K.D.</given-names></name><name><surname>Clerici</surname><given-names>C.</given-names></name><name><surname>Lephart</surname><given-names>E.D.</given-names></name><name><surname>Cole</surname><given-names>S.J.</given-names></name><name><surname>Heenan</surname><given-names>C.</given-names></name><name><surname>Castellani</surname><given-names>D.</given-names></name><name><surname>Wolfe</surname><given-names>B.E.</given-names></name><name><surname>Nechemias-Zimmer</surname><given-names>L.</given-names></name><name><surname>Brown</surname><given-names>N.M.</given-names></name><name><surname>Lund</surname><given-names>T.D.</given-names></name></person-group><article-title>S-Equol, a potent ligand for estrogen receptor &#x003b2;, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora</article-title><source>Am. J. Clin. Nutr.</source><year>2005</year><volume>81</volume><fpage>1072</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1093/ajcn/81.5.1072</pub-id><pub-id pub-id-type="pmid">15883431</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-10-00424-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart with the distribution of the participants in the study.</p></caption><graphic xlink:href="nutrients-10-00424-g001"/></fig><table-wrap id="nutrients-10-00424-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-10-00424-t001_Table 1</object-id><label>Table 1</label><caption><p>Comparison of lipid profile, glucose, glycated hemoglobin and uric acid between the pre- and post-interventionin the placebo (PLA) and isoflavone (ISO) groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="bottom" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pre</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">&#x00394;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
</th></tr><tr><th align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean &#x000b1; SE</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean &#x000b1; SE</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Groups)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Moments)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Groups * Moments)</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="middle" rowspan="1">Total Cholesterol (mg/dL)</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">210 &#x000b1; 8</td><td align="center" valign="middle" rowspan="1" colspan="1">197 &#x000b1; 7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;13.07 &#x000b1; 3.72</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.34</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.04</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.07</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">215 &#x000b1; 9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">214 &#x000b1; 9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;1.13 &#x000b1; 5.03</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">LDL (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">126 &#x000b1; 9</td><td align="center" valign="middle" rowspan="1" colspan="1">118 &#x000b1; 6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.54 &#x000b1; 4.29</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.34</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.24</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.21</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">133 &#x000b1; 8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">133 &#x000b1; 8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25 &#x000b1; 4.21</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">HDL (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">55.4 &#x000b1; 3.6</td><td align="center" valign="middle" rowspan="1" colspan="1">50.5 &#x000b1; 3.0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.54 &#x000b1; 1.27</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.25</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.07</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">58.1 &#x000b1; 3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.5 &#x000b1; 2.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.59 &#x000b1; 2.16</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">VLDL (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">24.7 &#x000b1; 3.1</td><td align="center" valign="middle" rowspan="1" colspan="1">23.5 &#x000b1; 3.0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.20 &#x000b1; 1.60</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.77</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.91</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.47</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">22.7 &#x000b1; 2.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.6 &#x000b1; 2.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88 &#x000b1; 2.17</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">Triglycerides (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">124 &#x000b1; 16</td><td align="center" valign="middle" rowspan="1" colspan="1">118 &#x000b1; 15</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.00 &#x000b1; 7.98</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.77</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.91</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.47</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">113 &#x000b1; 11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">118 &#x000b1; 10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.38 &#x000b1; 10.86</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">Glucose (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">86.6 &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">86.8 &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17 &#x000b1; 1.33</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.92</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.27</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.20</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">87.5 &#x000b1; 1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.5 &#x000b1; 1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;2.08 &#x000b1; 1.09</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">Glycated Hemoglobin (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">5.50 &#x000b1; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">5.52 &#x000b1; 0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 &#x000b1; 0.06</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.24</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.53</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.92</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">5.60 &#x000b1; 0.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.63 &#x000b1; 0.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03 &#x000b1; 0.05</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">Uric Acid (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">4.5 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04 &#x000b1; 0.13</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.79</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.68</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 &#x000b1; 0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.4 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.12 &#x000b1; 0.14</td></tr></tbody></table><table-wrap-foot><fn><p>PLA: placebo and exercise group; ISO: isoflavones and exercise group; LDL: Low density lipoprotein; HDL: High density lipoprotein; VLDL: Very low density lipoprotein.</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-10-00424-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-10-00424-t002_Table 2</object-id><label>Table 2</label><caption><p>Comparison of inflammatory and oxidative stress markers in the pre and post intervention moments in the placebo (PLA) and isoflavone (ISO) groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="bottom" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pre</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">&#x00394;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>p</italic>
</th></tr><tr><th align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean &#x000b1; SE</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean &#x000b1; SE</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Groups)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Moments)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(Groups * Moments)</th></tr></thead><tbody><tr><td colspan="2" align="left" valign="middle" rowspan="1">Interleukin-8 (pg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="bottom" rowspan="1" colspan="1">PLA</td><td align="center" valign="middle" rowspan="1" colspan="1">13.70 &#x000b1; 1.91</td><td align="center" valign="middle" rowspan="1" colspan="1">21.31 &#x000b1; 2.23</td><td align="center" valign="middle" rowspan="1" colspan="1">7.61 &#x000b1; 2.50</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.92</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.001</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.55</td></tr><tr><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.52 &#x000b1; 1.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.13 &#x000b1; 1.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.61 &#x000b1; 2.23</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">Interleukin-6 (pg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="bottom" rowspan="1" colspan="1">PLA</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.54 &#x000b1; 0.39</td><td align="center" valign="bottom" rowspan="1" colspan="1">1.30 &#x000b1; 0.32</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.24 &#x000b1; 0.27</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.76</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.22</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.98</td></tr><tr><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">1.42 &#x000b1; 0.21</td><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">1.19 &#x000b1; 0.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.23 &#x000b1; 0.25</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">FRAP (umol/L eq. Trolox)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="bottom" rowspan="1" colspan="1">PLA</td><td align="center" valign="middle" rowspan="1" colspan="1">124.31 &#x000b1; 5.24</td><td align="center" valign="middle" rowspan="1" colspan="1">123.18 &#x000b1; 5.67</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.13 &#x000b1; 3.48</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.65</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.39</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.73</td></tr><tr><td align="center" valign="bottom" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">122.47 &#x000b1; 2.83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">119.85 &#x000b1; 3.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-2.63 &#x000b1; 2.58</td></tr><tr><td colspan="3" align="left" valign="middle" rowspan="1">TBARS (umol/L TBA-RS)</td><td align="center" valign="bottom" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="bottom" rowspan="1" colspan="1">PLA</td><td align="center" valign="middle" rowspan="1" colspan="1">24.65 &#x000b1; 1.08</td><td align="center" valign="middle" rowspan="1" colspan="1">24.42 &#x000b1; 1.17</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.23 &#x000b1; 0.72</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.72</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.38</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.70</td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">24.40 &#x000b1; 0.61</td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">23.82 &#x000b1; 0.66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.58 &#x000b1; 0.56</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">SOD (SOD/mg prot)</td><td align="center" valign="top" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PLA</td><td align="center" valign="top" rowspan="1" colspan="1">0.190 &#x000b1; 0.007</td><td align="center" valign="top" rowspan="1" colspan="1">0.194 &#x000b1; 0.008</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003 &#x000b1; 0.010</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.20</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.24</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.50</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.176 &#x000b1; 0.007</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.193 &#x000b1; 0.008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.012 &#x000b1; 0.008</td></tr></tbody></table><table-wrap-foot><fn><p>PLA: placebo and exercise group; ISO: isoflavones and exercise group; FRAP: plasma ferric reduction capacity; TBARS: thiobarbituric acid reactive substances; SOD: superoxide dismutase.</p></fn></table-wrap-foot></table-wrap></floats-group></article>